StonvexLoading…
StonvexStonvexStonvexCore line items from ATAT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.40B | $992.96M | $657.19M | $328.10M |
Operating Income | $329.85M | $222.25M | $130.15M | $23.92M |
Net Income | $231.80M | $174.72M | $103.82M | $14.22M |
EPS (Diluted) | $0.55 | $0.42 | $0.25 | $0.04 |
Total Assets | $1.31B | $1.08B | $927.76M | $690.43M |
Total Liabilities | $798.89M | $675.81M | $637.61M | $518.27M |
Cash & Equivalents | $472.46M | $495.73M | $400.12M | $230.41M |
Free Cash Flow OCF − CapEx | $272.70M | $228.75M | $274.22M | $35.85M |
Shares Outstanding | 419.30M | 417.23M | 414.82M | 381.60M |